Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Hyperlipidemia Drugs Market to reach USD XX billion by the end of 2030.

Global Hyperlipidemia Drugs Market Size study & Forecast, by Drug Class (Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, PCSK9 Inhibitors, Combination, Miscellaneous) and Regional Analysis, 2023-2030

Product Code: HLSDT-92903035
Publish Date: 20-10-2023
Page: 200

Global Hyperlipidemia Drugs Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Hyperlipidemia drugs, also known as lipid-lowering drugs or lipid-lowering agents, are medications used to manage and treat high levels of lipids (fats) in the blood, particularly cholesterol and triglycerides. Hyperlipidemia is a condition characterized by elevated levels of lipids, which can lead to an increased risk of cardiovascular diseases such as heart attacks and strokes. The Hyperlipidemia Drugs market is expanding because of factors such as the rising prevalence of cardiovascular diseases and the rise in the prevalence of hyperlipidemia across the globe.

The rising prevalence of hyperlipidemia, primarily attributed to unhealthy lifestyles, sedentary habits, and poor dietary choices, has driven the demand for lipid-lowering medications. The World Health Organisation (WHO) estimates that hypercholesterolemia causes more than 2.6 million deaths annually. Additionally, Hyperlipidemia, also known as high cholesterol, is a significant risk factor for cardiovascular diseases such as heart disease and stroke. The rising prevalence of cardiovascular disease worldwide has been a driving factor in the growth of Hyperlipidemia Drugs. The American College of Cardiology reports that by 2030, there would be around 29 million Americans with a diagnosis of cardiovascular disease, up from 6.95 million in the year 2021. In 2020, 244.1 million people worldwide were living with ischemic heart disease. Thus, the rising prevalence of cardiovascular diseases is driving the market growth. In addition, increasing clinical trials on drug development and rising healthcare expenditure are creating new opportunities for market growth. However, the availability of different treatments, adverse effects, and safety concerns stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Hyperlipidemia Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, rising prevalence of cardiovascular disease, advancement in drug development, rising number of clinical trials activities and healthcare expenditure in the region. Whereas, Asia Pacific is projected to grow a significant rate owing to factors such as the rising prevalence of heart diseases, rising healthcare expenditure, rising healthcare expenditure, active participation of government in the region.

Major market player included in this report are:
Amgen Inc.
AstraZeneca PLC
Daiichi Sankyo Company Limited
Eli Lilly and Company
Esperion Therapeutics Inc
GlaxoSmithKline Pharmaceuticals Limited (GlaxoSmithKline Plc)
Immuron Limited
Ionis Pharmaceuticals Inc.
Merck & Co. Inc.
Sanofi S.A.

Recent Developments in the Market:
Ø In January 2023, AstraZeneca entered signed an agreement to acquire CinCor Pharma, Inc., a clinical-stage biopharmaceutical business based in the US that specializes in developing innovative medications for chronic kidney disease and safe, uncontrolled hypertension.
Ø In May 2022, Zydus Lifesciences launched its bempedoic acid drug under the trade name Bemdac in India to treat high levels of harmful cholesterol.

Global Hyperlipidemia Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Drug Class, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:
Bile Acid Sequestrants
Cholesterol Absorption Inhibitors
Fibric Acid Derivatives
PCSK9 Inhibitors

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Hyperlipidemia Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Hyperlipidemia Drugs Market, by Drug Class, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Hyperlipidemia Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Hyperlipidemia Drugs Market Dynamics
3.1. Hyperlipidemia Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Rising prevalence of cardiovascular diseases Rise in prevalence of hyperlipidemia across the globe
3.1.2. Market Challenges Availability of different treatments Adverse effects and safety concerns
3.1.3. Market Opportunities Increasing clinical trials on drug development Rising healthcare expenditure
Chapter 4. Global Hyperlipidemia Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Hyperlipidemia Drugs Market, by Drug Class
5.1. Market Snapshot
5.2. Global Hyperlipidemia Drugs Market by Drug Class, Performance – Potential Analysis
5.3. Global Hyperlipidemia Drugs Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Hyperlipidemia Drugs Market, Sub Segment Analysis
5.4.1. Statins
5.4.2. Bile Acid Sequestrants
5.4.3. Cholesterol Absorption Inhibitors
5.4.4. Fibric Acid Derivatives
5.4.5. PCSK9 Inhibitors
5.4.6. Combination
5.4.7. Miscellaneous
Chapter 6. Global Hyperlipidemia Drugs Market, Regional Analysis
6.1. Top Leading Countries
6.2. Top Emerging Countries
6.3. Hyperlipidemia Drugs Market, Regional Market Snapshot
6.4. North America Hyperlipidemia Drugs Market
6.4.1. U.S. Hyperlipidemia Drugs Market Drug Class breakdown estimates & forecasts, 2020-2030
6.4.2. Canada Hyperlipidemia Drugs Market
6.5. Europe Hyperlipidemia Drugs Market Snapshot
6.5.1. U.K. Hyperlipidemia Drugs Market
6.5.2. Germany Hyperlipidemia Drugs Market
6.5.3. France Hyperlipidemia Drugs Market
6.5.4. Spain Hyperlipidemia Drugs Market
6.5.5. Italy Hyperlipidemia Drugs Market
6.5.6. Rest of Europe Hyperlipidemia Drugs Market
6.6. Asia-Pacific Hyperlipidemia Drugs Market Snapshot
6.6.1. China Hyperlipidemia Drugs Market
6.6.2. India Hyperlipidemia Drugs Market
6.6.3. Japan Hyperlipidemia Drugs Market
6.6.4. Australia Hyperlipidemia Drugs Market
6.6.5. South Korea Hyperlipidemia Drugs Market
6.6.6. Rest of Asia Pacific Hyperlipidemia Drugs Market
6.7. Latin America Hyperlipidemia Drugs Market Snapshot
6.7.1. Brazil Hyperlipidemia Drugs Market
6.7.2. Mexico Hyperlipidemia Drugs Market
6.8. Middle East & Africa Hyperlipidemia Drugs Market
6.8.1. Saudi Arabia Hyperlipidemia Drugs Market
6.8.2. South Africa Hyperlipidemia Drugs Market
6.8.3. Rest of Middle East & Africa Hyperlipidemia Drugs Market

Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Amgen Inc. Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
7.3.2. AstraZeneca PLC
7.3.3. Daiichi Sankyo Company Limited
7.3.4. Eli Lilly and Company
7.3.5. Esperion Therapeutics Inc
7.3.6. GlaxoSmithKline Pharmaceuticals Limited (GlaxoSmithKline Plc)
7.3.7. Immuron Limited
7.3.8. Ionis Pharmaceuticals Inc.
7.3.9. Merck & Co. Inc.
7.3.10. Sanofi S.A.
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now